Chiron, Ciba Pharmaceuticals regulatory update

The FDA approved Aredia (pamidronate disodium for injection) to treat osteolytic bone lesions of multiple myeloma, a malignancy of plasma cells in bone marrow, in conjunction with chemotherapy.

Aredia is developed and manufactured by Ciba (Summit, N.J) and marketed exclusively in the U.S. by CHIR. ...